Panel Discussion: Conducting a Strategic Analysis of Protein Misfolding Therapeutics

Time: 2:00 pm
day: Day Two


• What are the strengths of companies active in developing protein misfolding therapeutics?
• What is a bird’s eye view of the space in terms of how money has flowed in/out?
• What do companies in this space need to change or improve to accelerate their scientific progress?
• What is the market opportunity and unmet need that makes protein misfolding therapeutics an attractive but high hanging fruit in terms of therapeutic potential?